Semaglutide tablets launched in China

Oral semaglutide, as a new type of oral hypoglycemic drug, is specially developed for patients with type 2 diabetes. It activates the GLP-1 receptor, promotes insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, thereby achieving the goal of effectively lowering blood sugar. This mechanism makes semaglutide a powerful tool for controlling blood sugar in patients with type 2 diabetes.

It is worth mentioning that semaglutide not only has hypoglycemic effects, but also helps control weight. It helps with weight loss to some extent by delaying gastric emptying and increasing the feeling of fullness. However, it needs to be emphasized that although semaglutide shows a certain weight loss effect, its main effect is still to lower blood sugar and is not a specialized weight loss drug. Although semaglutide tablets currently have a certain weight loss effect in treating patients with type 2 diabetes, this drug is not approved for weight loss. The domestically marketed semaglutide injection passed the weight loss indication on June 25. People who need to lose weight can consider semaglutide injection.

In terms of safety, semaglutide has been verified by multiple clinical trials, but patients still need to follow medical advice and pay attention to physical reactions when using it. Possible side effects include gastrointestinal discomfort, risk of hypoglycemia (especially when used in combination with sulfonylureas or insulin), and potential allergic reactions.

Regarding use and storage, patients should determine the dosage according to the doctor's guidance, and keep the drug storage environment dry and away from moisture to ensure the stability of the drug effect.

In summary, oral semaglutide provides a new treatment option for patients with type 2 diabetes due to its unique hypoglycemic mechanism and potential weight control effect. During use, patients should follow medical advice and pay attention to observing body reactions to ensure the safety and effectiveness of the drug.

Although semaglutide tablets have been approved in China this year, patients may find it inconvenient to purchase the new drug in the early stages of its launch. At this time, we can pay attention to the situation of semaglutide tablets that have been launched overseas. For example, the overseas version of 3mg*100 tablets costs about 2,000 yuan. There are also other specifications of oral semaglutide available in overseas markets. For more questions about this drug, it is recommended to consult an overseas medical consultant for professional answers.